Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: A multi-tracer PET study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  NeuroImage

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1016/J.NEUROIMAGE.2005.09.044PMID 16378735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET Studies of Net Blood—Brain Clearance of FDOPA to Human Brain: Age-Dependent Decline of [18F]Fluorodopamine Storage Capacity

  2005cited by this paper
• Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.

  2005cited by this paper
• Brain kinetics of L-[Β-11 C]DOPA in humans studied by positron emission tomography

  2005cited by this paper
• How useful is [123I]β-CIT SPECT in clinical practice?

  2005cited by this paper
• How useful is [123I]beta-CIT SPECT in clinical practice?

  2005cited by this paper
• Isoflurane induces dopamine transporter trafficking into the cell cytoplasm

  2004cited by this paper
• 6-18F-L-DOPA imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys

  2004cited by this paper
• Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.

  2004cited by this paper
• Potential of [18F]β‐CFT‐FE (2β‐carbomethoxy‐3β‐(4‐fluorophenyl)‐8‐(2‐[18F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain

  2004cited by this paper
• Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.

  2004cited by this paper
• Isoflurane Alters the Amount of Dopamine Transporter Expressed on the Plasma Membrane in Humans

  2004cited by this paper
• Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET

  2004cited by this paper
• Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.

  2004cited by this paper
• Positron emission tomography of striatal serotonin transporters in Parkinson disease.

  2003cited by this paper
• Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

  2003cited by this paper
• Decreased plasma membrane expression of striatal dopamine transporter in aging.

  2003cited by this paper
• Interaction of Isoflurane with the Dopamine Transporter

  2003cited by this paper
• Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter.

  2003cited by this paper
• General Anesthetic Actions on Norepinephrine, Dopamine, and γ-Aminobutyric Acid Transporters in Stably Transfected Cells

  2002cited by this paper
• Quantitative [18F]Fluorodopa/PET and Histology of Fetal Mesencephalic Dopaminergic Grafts to the Striatum of MPTP-Poisoned Minipigs

  2002cited by this paper
• General Anesthetic Actions on Norepinephrine, Dopamine, and &ggr;-Aminobutyric Acid Transporters in Stably Transfected Cells

  2002cited by this paper
• Orthostatic hypotension from sympathetic denervation in Parkinson’s disease

  2002cited by this paper
• Age‐related changes in the striatal dopaminergic system in the living brain: A multiparametric PET study in conscious monkeys

  2002cited by this paper
• No effect of age and estrogen on aromatic L- amino acid decarboxylase activity in rhesus monkey brain.

  2002cited by this paper
• Template Images for Nonhuman Primate Neuroimaging: 2. Macaque

  2001cited by this paper
• Loss of metabolites from monkey striatum during PET with FDOPA

  2001cited by this paper
• Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6‐[18F]fluoro‐L‐dopa studied with PET in normal control and Parkinson's disease subjects

  2000cited by this paper
• Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization.

  2000cited by this paper
• In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

  2000cited by this paper
• In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long‐term MPTP‐induced parkinsonism

  2000cited by this paper
• Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

  2000cited by this paper
• Analysis of Four Dopaminergic Tracers Kinetics Using Two Different Tissue Input Function Methods

  2000cited by this paper
• Dopamine transporter loss and clinical changes in MPTP-lesioned primates.

  1999cited by this paper
• (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis.

  1999cited by this paper
• ()-α-[11C]Dihydro- tetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis

  1999cited by this paper
• Assessment of Extrastriatal Vesicular Monoamine Transporter Binding Site Density Using Stereoisomers of [11C]Dihydrotetrabenazine

  1999cited by this paper
• FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa

  1999cited by this paper
• Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease

  1999cited by this paper
• Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.

  1999cited by this paper
• Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

  1998cited by this paper
• Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

  1998cited by this paper
• A simple synthesis of [11C]dihydrotetrabenazine (DTBZ).

  1997cited by this paper
• Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]β-CIT SPECT

  1997cited by this paper
• The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat.

  1997cited by this paper
• Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine

  1997cited by this paper
• Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain

  1997cited by this paper
• Dopamine transporters decrease with age.

  1996cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper
• Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

  1996cited by this paper
• Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters.

  1996cited by this paper
• Regulation of DOPA Decarboxylase Activity in Brain of Living Rat

  1995cited by this paper
• PET imaging of neocortical monoaminergic terminals in Parkinson's disease

  1995cited by this paper
• Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies?

  1995cited by this paper
• Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.

  1995cited by this paper
• Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.

  1995cited by this paper
• Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease

  1995cited by this paper
• Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects.

  1994cited by this paper
• Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions

  1994cited by this paper
• Synthesis of the racemate and individual enantiomers of [11C]methylphenidate for studying presynaptic dopaminergic neuron with positron emission tomography

  1994cited by this paper
• Age‐dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their grandchildren

  1994cited by this paper
• [3H]CFT ([3H]WIN 35,428) accumulation in dopamine regions of monkey brain: comparison of a mature and an aged monkey.

  1993cited by this paper
• Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.

  1993cited by this paper
• In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428

  1993cited by this paper
• Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa.

  1992cited by this paper
• Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.

  1992cited by this paper
• Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.

  1991cited by this paper
• Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.

  1991cited by this paper
• MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate.

  1990cited by this paper
• Catecholamine uptake sites in mouse brain: distribution determined by quantitative [3H]mazindol autoradiography.

  1989cited by this paper
• A simple synthesis

  1989cited by this paper
• Monoamine re‐uptake sites in the human brain evaluated in vivo by means of 11C‐nomifensine and positron emission tomography: the effects of age and Parkinson's disease

  1988cited by this paper
• The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.

  1988cited by this paper
• Aminergic systems in Alzheimer's disease and Parkinson's disease

  1987cited by this paper
• Parkinson's disease and dementia

  1987cited by this paper
• The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolites.

  1986cited by this paper
• Positron emission tomography.

  1986cited by this paper
• N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.

  1986cited by this paper
• Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

  1985cited by this paper
• Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.

  1985cited by this paper
• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

  1985cited by this paper
• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  1983cited by this paper
• REGIONAL DISTRIBUTION OF ENZYMES ASSOCIATED WITH NEUROTRANSMISSION BY MONOAMINES, ACETYLCHOLINE AND GABA IN THE HUMAN BRAIN

  1978cited by this paper
• A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.

  1972cited by this paper
• OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN

  1972cited by this paper
• Journal of Cerebral Blood Flow and Metabolism 6-[18p]fluoro-l-dopa Metabolism in Living Human Brain: a Comparison of Six Analytical Methods

  year unknowncited by this paper

• Molecular Imaging Studies of Alcohol Use Disorder.

  2023cites this paper
• Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Female Minipigs.

  2022cites this paper
• PET imaging in animal models of Parkinson's disease.

  2022cites this paper
• Co-registration of imaging modalities (MRI, CT and PET) to perform frameless stereotaxic robotic injections in the common marmoset.

  2021cites this paper
• Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Minipigs

  2021cites this paper
• MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease

  2021cites this paper
• Molecular imaging of schizophrenia: neurochemical findings in a heterogeneous and evolving disorder.

  2020cites this paper
• PET Imaging of Vesicular Monoamine Transporters

  2020cites this paper
• Relationship between [123I]‐FP‐CIT SPECT and clinical progression in Parkinson's disease

  2017cites this paper
• A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain.

  2017cites this paper
• Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms

  2016cites this paper
• Interpreting DTBZ binding data in rodent: Inherent variability and compensation

  2016cites this paper
• PET Imaging of Serotonin Transporters with 4-[18F]-ADAM in a Parkinsonian Rat Model with Porcine Neural Xenografts

  2016cites this paper
• Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.

  2015cites this paper
• How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?

  2015cites this paper
• Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.

  2014cites this paper
• Radiosynthesis and Validation of 18F-FP-CMT, a Phenyltropane with Superior Properties for Imaging the Dopamine Transporter in Living Brain

  2014cites this paper
• Radioligands for imaging vesicular monoamine transporters

  2014cites this paper
• Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.

  2014cites this paper
• Dopamine: PET Imaging and Parkinson Disease.

  2013cites this paper
• Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

  2012cites this paper
• Quantitative analysis of binding sites for 9‐fluoropropyl‐(+)‐dihydrotetrabenazine ([18F]AV‐133) in a MPTP‐lesioned PD mouse model

  2012cites this paper
• Animal Models of Movement Disorders

  2012influential citation
• No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease

  2012cites this paper
• Decline in prefrontal catecholamine synthesis explains age-related changes in cognitive speed beyond regional grey matter atrophy

  2012cites this paper
• Antiparkinsonian Mechanism of Electroconvulsive Therapy in MPTP-Lesioned Non-Human Primates

  2012cites this paper
• In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET

  2012influential citation
• Molecular imaging and the neuropathologies of Parkinson's disease.

  2012cites this paper
• Brain Imaging in Behavioral Neuroscience

  2012cites this paper
• Electroconvulsive Therapy Alters Dopamine Signaling in the Striatum of Non-human Primates

  2011cites this paper
• Quantification of Brain Function and Neurotransmission System In Vivo by Positron Emission Tomography: A Review of Technical Aspects and Practical Considerations in Preclinical Research

  2011cites this paper
• Elevated [18F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease

  2010cites this paper
• Mouse models in neurological disorders: applications of non-invasive imaging.

  2010cites this paper
• EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP

  2010cites this paper
• Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.

  2010cites this paper
• The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.

  2010cites this paper
• Progress in Psychopharmacotherapy though Molecular Imaging

  2010cites this paper
• Approaches PET Studies of Cerebral Levodopa Metabolism : A Review of Clinical Findings and Modeling

  2009cites this paper
• Imaging Techniques in Large Animals

  2009cites this paper
• PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches

  2009cites this paper
• VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease

  2008cites this paper
• Use of 11C-(+)-α-dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease

  2008cites this paper
• Utilización de la 11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

  2008cites this paper
• [Use of 11C-(+)-alpha -dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease].

  2008cites this paper
• In Vitro Imaging Techniques in Neurodegenerative Diseases

  2007influential citation
• Animal Models of Neurodegenerative Disease: Insights from In vivo Imaging Studies

  2007cites this paper
• Nonhuman primate models of Parkinson's disease.

  2007cites this paper
• Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study.

  2007cites this paper
• ‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [18F]‐fluoro‐L‐DOPA‐PET investigation

  2007cites this paper
• Differential Loss of Presynaptic Dopaminergic Markers in Parkinsonian Monkeys

  2007cites this paper
• Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease.

  2007cites this paper